(1306–1346) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II

Monday, October 27, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

anti-beta-2-glycoprotein-1 Iga Antibodies Facilitate Macrophage Cholesterol Loading and Influence Coronary Atherosclerosis Progression in a Dose-dependent Manner in Rheumatoid Arthritis
Abstract Poster Presenter: George Karpouzas, MD (he/him/his) – Harbor-UCLA Medical Center
10:30 AM - 12:30 PM Central Time

Assessment of Lipid Abnormalities After Initiation of a JAK Inhibitor in Rheumatoid Arthritis in Clinical Practice
Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
10:30 AM - 12:30 PM Central Time

Association Between Physical Function and Nutritional Status in Rheumatoid Arthritis Patients
Abstract Poster Presenter: Yasumori Sobue, MD, PhD – Sobue Orthopedic Clinic Yatomi
10:30 AM - 12:30 PM Central Time

Cardiac Biomarkers and Prediction of Major Cardiovascular Events in Rheumatoid Arthritis: Results from the ESPOIR Cohort
Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
10:30 AM - 12:30 PM Central Time

Chest x-Ray and pulmonary function tests are not sensitive for screening intertitial lung disease in reumatoid arthritis
Abstract Poster Presenter: Jesús Loarce, Sr, MD – Ramón y Cajal University Hospital
10:30 AM - 12:30 PM Central Time

Decade-Based Trends in First Remission Among Rheumatoid Arthritis Patients: A Population-Based Study
Abstract Poster Presenter: Georges El Hasbani, MD – Mayo Clinic
10:30 AM - 12:30 PM Central Time

Diagnostic Delay in Rheumatoid Arthritis and its Impact on Radiographic Outcomes: A Systematic Review and Meta-analysis of 100,066 Patients
Abstract Poster Presenter: Mohamed Abdelsalam, MSc, MBBCH – MUST University
10:30 AM - 12:30 PM Central Time

Does Moderate Alcohol Use Lower Disease Activity Among Patients with Rheumatoid Arthritis?
Abstract Poster Presenter: Sarah Crisci, MS, MPH – Thermo Fisher Scientific
10:30 AM - 12:30 PM Central Time

Effectiveness of new initiators of tofacitinib and other biologic/targeted synthetic DMARDs in patients with rheumatoid arthritis
Abstract Poster Presenter: Katherine Liao, MD, MPH – Brigham and Women's Hospital
10:30 AM - 12:30 PM Central Time

Efficacy and safety of janus kinase inhibitors in diffuse interstitial lung disease in rheumatoid arthritis. Systematic review
Abstract Poster Presenter: Olga Compán Fernández, MD. – Rheumatology Service, University Hospital of Salamanca
10:30 AM - 12:30 PM Central Time

Efficacy of Olokizumab in Treating Comorbid Depression in Patients with Rheumatoid Arthritis: Results of a Single-Center Randomized Controlled Trial
Abstract Poster Presenter: Sofia Kuzkina, MD (she/her/hers) – R-Pharm
10:30 AM - 12:30 PM Central Time

Evolution of patients with active rheumatoid arthritis: analysis of disease activity trajectories in a tertiary‑care rheumatology department
Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
10:30 AM - 12:30 PM Central Time

Exploring the Factors Associated with the Discontinuation of Tofacitinib in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
Abstract Poster Presenter: Yao-fan Fang, MD – Chang-Gung memorial hospital
10:30 AM - 12:30 PM Central Time

High Rheumatoid Factor Titers and Biologic Persistence in RA: Beyond TNF Inhibitors
Abstract Poster Presenter: Sara Salas Santamaria, MD, MEd – Hospital Universitario La Paz
10:30 AM - 12:30 PM Central Time

High-resolution thermography and Artificial Intelligence to evaluate and classify Rheumatoid Arthritis
Abstract Poster Presenter: Liam O'Neil, MD, MHS – University of Manitoba
10:30 AM - 12:30 PM Central Time

Inflammatory Rheumatic Diseases in IDH-mutated Myeloid Neoplasms: Clinical Spectrum and Response to IDH Inhibitors
Abstract Poster Presenter: Romain Stammler, n/a (he/him/his) – Assistance Publique des Hôpitaux de Paris
10:30 AM - 12:30 PM Central Time

Mid‐Infrared Spectroscopy for Enhanced Diagnosis of Rheumatic Diseases
Abstract Poster Presenter: Gilad Halpert, PhD – Reichman University
10:30 AM - 12:30 PM Central Time

Mortality Trends of Hypertension in Patients with Rheumatoid Arthritis in the United States (1999–2020)
Abstract Poster Presenter: Areeba Minhaj, MD – University of South Dakota
10:30 AM - 12:30 PM Central Time

Naturalized Language Processing Based Extraction of Rheumatoid Arthritis Disease Activity Measures from the Electronic Health Record
Abstract Poster Presenter: Elizabeth Park, MD, MSc – Columbia University Medical Center
10:30 AM - 12:30 PM Central Time

Physical Function Across Age in Patients With Rheumatoid Arthritis and Population Controls: A Cross-Sectional Study of Four Performance Measures
Abstract Poster Presenter: Saskia Truijen, MSc – Maastricht University Medical Centre+
10:30 AM - 12:30 PM Central Time

Plasma levels of monounsaturated fatty acids (MUFAs) positively correlate with disease activity in patients with rheumatoid arthritis (RA)
Abstract Poster Presenter: Beatriz Hanaoka, MD, MSc – Oklahoma University Health Sciences Center
10:30 AM - 12:30 PM Central Time

Plasma Matrix Metalloproteinases and Heart Failure Outcomes in Rheumatoid Arthritis
Abstract Poster Presenter: Tate Johnson, MD – University of Nebraska Medical Center
10:30 AM - 12:30 PM Central Time

Predicting mortality of rheumatoid arthritis in China: A nation-wide cohort study
Abstract Poster Presenter: Kangping Huang, BSc, -None- (he/him/his) – Peking Union Medical College
10:30 AM - 12:30 PM Central Time

Predictors of Interstitial Lung Disease Progression in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Bryant England, MD, PhD – University of Nebraska Medical Center
10:30 AM - 12:30 PM Central Time

Preliminary Result of Investigating the Response of Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) Associated SNPs: One Cohort Study
Abstract Poster Presenter: YU Chen, MD, MSc, BA (she/her/hers) – 1. Division of Rheumatology, Allergy and Immunology, Far Eastern Memorial Hospital, New Taipei City, Taiwan, R.O.C.
10:30 AM - 12:30 PM Central Time

Protein-Specific Anti-Malondialdehyde-Acetaldehyde Antibodies and Cardiovascular Disease Outcomes in Rheumatoid Arthritis
Abstract Poster Presenter: Julia King, BS – Creighton University
10:30 AM - 12:30 PM Central Time

Relationship Between Circulating Bacterial Small RNAs, Methotrexate Response, and Microbiome in New Onset Rheumatoid Arthritis
Abstract Poster Presenter: Carolina Ramirez Becerra, MD – Vanderbilt University Medical Center
10:30 AM - 12:30 PM Central Time

Retrospective Analysis of Factors Associated With Fracture in 2855 Patients With Rheumatoid Arthritis, Stratified by Steroid Use
Abstract Poster Presenter: Jonathan Barnes, MBBS – Morecambe Bay NHS Trust
10:30 AM - 12:30 PM Central Time

Short-Chain Fatty Acids and Their Gut Microbial Metabolic Pathways Distinguish Rheumatoid Arthritis in Discordant Monozygotic Twins
Abstract Poster Presenter: Rebecca Blank, MD, PhD – NYU
10:30 AM - 12:30 PM Central Time

Similar Negative Effects of Fatigue on Physical Activity in Persons with Rheumatoid Arthritis and Healthy Controls: A Patient-Control Study
Abstract Poster Presenter: Sofia Ramiro, MD, PhD – Leiden University Medical Center
10:30 AM - 12:30 PM Central Time

Six-Minute Walk Distance as a Functional Measure in Rheumatoid Arthritis-associated Interstitial Lung Disease Reflecting Both Lung and Joint Involvement
Abstract Poster Presenter: Sung Hae Chang, MD, PhD, MPH – Soonchunhyang University College of Medicine
10:30 AM - 12:30 PM Central Time

Systematic Literature Review of Digital Sleep Outcomes and Endpoints Used to Assess Rheumatoid Arthritis
Abstract Poster Presenter: Anna fishbein, MD – Sanofi
10:30 AM - 12:30 PM Central Time

The Association Between Glucagon-Like Peptide-1 Receptor Agonist and Rheumatoid Arthritis: A Population-Based Case Control Study
Abstract Poster Presenter: Mohammad Naffaa, MD – Galilee Medical Center
10:30 AM - 12:30 PM Central Time

The Association Between Insomnia and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 546,822 Patients
Abstract Poster Presenter: Mohamed Abdelsalam, MSc, MBBCH – MUST University
10:30 AM - 12:30 PM Central Time

The Association of Rheumatoid Arthritis in Patients with Vitiligo: Systematic Review and Meta-Analysis
Abstract Poster Presenter: Nattanicha Chaisrimaneepan, MD – Texas Tech University Health Sciences Center
10:30 AM - 12:30 PM Central Time

Transcriptomic biomarkers of progression from undifferentiated arthritis to rheumatoid arthritis
Abstract Poster Presenter: Damini Jawaheer, PhD, MS – Northwestern University
10:30 AM - 12:30 PM Central Time

Trends In Incidence and Risk factors For Incident Venous Thromboembolism in Patients with Rheumatoid Arthritis: A Population-Based Retrospective Cohort Study
Abstract Poster Presenter: Noah Frechette, BS – Mayo Clinic
10:30 AM - 12:30 PM Central Time

Upregulated TLR Signaling Identified in Difficult-to-Treat RA: A Propensity Score–Matched Transcriptome Study
Abstract Poster Presenter: Yoshinori Nishiura, MD – Japan Red Cross Okayama Hospital
10:30 AM - 12:30 PM Central Time

The Impact of Age on Health-Related Quality of Life in Patients With Rheumatoid Arthritis Compared to Population Controls: A Cross-Sectional Analysis
Abstract Poster Presenter: Saskia Truijen, MSc – Maastricht University Medical Centre+
10:30 AM - 12:30 PM Central Time

Sex and reproductive stage modify the role of endogenous estrogens on coronary atherosclerosis in rheumatoid arthritis and differences reflect effects on inflammation and cholesterol metabolism
Abstract Poster Presenter: George Karpouzas, MD (he/him/his) – Harbor-UCLA Medical Center
10:30 AM - 12:30 PM Central Time

Systematic Review of Mobility in Rheumatoid Arthritis with Digitally Measured Objective Assessment
Abstract Poster Presenter: Anna fishbein, MD – Sanofi